Jul 23, 2025, 08:05

RFA: The Role of Health Policy and Health Insurance in Improving Cancer Prevention, Early Detection, and Treatment Services

This RFA seeks rapid‐learning health policy research that evaluates how recent federal, state, and local insurance reforms impact cancer prevention, screening, treatment, and survivorship. Studies should leverage natural experiments—such as Medicaid expansion, ACA marketplaces, and state-level policy changes—to measure effects on access, equity, affordability, adequacy, and administrative simplicity of cancer services across diverse populations.

Eligibility Criteria:

Must be a full-time faculty investigator at a U.S. academic institution or eligible non-profit.
RFA open to resubmissions only (previous applicants may revise and reapply).
Independent principal investigators at any career stage.

Funding Details:

Mechanism: American Cancer Society Research Scholar Grant (RSG).
Project Period: Up to 4 years (some projects may complete in 2 years).
Budget Cap: $215,000 direct costs per year + 10% indirect costs.

Key Dates:

Letter of Intent Deadline: See ACS site for RSG timelines
Full Application Deadline: See ACS site for RSG timelines

Where to Apply & Further Information:

Application Portal: ACS Grants Management at ProposalCentral
RFA Guidelines: Available under Clinical & Cancer Control RSG program on the ACS website
Questions: Contact [email protected] with code “Health Policy RFA” in subject

ACA access to care American Cancer Society Cancer Prevention early detection Health Disparities health insurance health policy Implementation Research Medicaid Expansion RSG

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Paolo Tarantino: AACR Journals' Power Move for Reviewers

Best Immunotherapy Highlights from ESMO TAT ASIA 2025 You Shouldn't Miss

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership

Mohit Manrao: FDA Grants Priority Review for sBLA in Resectable Early-Stage Gastric and GEJ Cancers